Venrock Adviser, LLC 13F holdings, Q1 2025
Holdings as of March 31, 2025 · filings on SEC EDGAR · latest filing →
Venrock Adviser, LLC disclosed 37 US equity positions worth $1.2bn in its Q1 2025 13F filing. The largest position was APGE at 27.0% of the reported book, followed by METSERA INC and OCUL. Against the Q4 2024 filing, it opened 4 new positions, added to 4 and reduced 7 among the top 37 holdings.
What did Venrock Adviser, LLC own in Q1 2025? Top 37 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q4 2024 |
|---|---|---|---|---|---|---|---|
| 1 | APGE APOGEE THERAPEUTICS INC | Healthcare | 27.0% | $317.3m | 8,493,321 | 0% | held |
| 2 | METSERA INC | 8.7% | $102.1m | 3,750,662 | – | new | |
| 3 | OCUL OCULAR THERAPEUTIX INC | Healthcare | 8.0% | $93.5m | 12,762,462 | 0% | held |
| 4 | ELVN ENLIVEN THERAPEUTICS INC | Healthcare | 6.7% | $79.2m | 4,026,331 | 0% | held |
| 5 | 4XC1 KALVISTA PHARMACEUTICALS INC | 6.6% | $77.4m | 6,703,985 | 7% | added | |
| 6 | VRDN VIRIDIAN THERAPEUTICS INC | Healthcare | 4.5% | $52.3m | 3,882,709 | 0% | held |
| 7 | PHVS PHARVARIS N V | 4.2% | $48.9m | 3,112,720 | -3% | reduced | |
| 8 | SYRE SPYRE THERAPEUTICS INC | 3.7% | $43.3m | 2,685,448 | 0% | held | |
| 9 | ORKA ORUKA THERAPEUTICS INC | Healthcare | 3.6% | $42.6m | 4,148,428 | 26% | added |
| 10 | PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 3.2% | $37.5m | 989,985 | 0% | held |
| 11 | COGT COGENT BIOSCIENCES INC | Healthcare | 2.9% | $34.0m | 5,684,411 | 0% | held |
| 12 | DNTH DIANTHUS THERAPEUTICS INC | Healthcare | 2.7% | $31.6m | 1,744,373 | 0% | held |
| 13 | DYN DYNE THERAPEUTICS INC | Healthcare | 1.9% | $22.7m | 2,173,913 | 0% | held |
| 14 | CDTX CIDARA THERAPEUTICS INC | 1.9% | $22.6m | 1,051,518 | 37% | added | |
| 15 | ENGENE HOLDINGS INC | 1.9% | $22.6m | 5,046,414 | 0% | held | |
| 16 | ERAS ERASCA INC | Healthcare | 1.9% | $22.2m | 16,216,216 | 0% | held |
| 17 | ORIC ORIC PHARMACEUTICALS INC | Healthcare | 1.5% | $17.8m | 3,182,527 | -28% | reduced |
| 18 | UPB UPSTREAM BIO INC | 1.2% | $14.0m | 2,295,319 | 0% | held | |
| 19 | CATBUSD ASTRIA THERAPEUTICS INC | 1.1% | $13.1m | 2,457,348 | 0% | held | |
| 20 | CGEM CULLINAN THERAPEUTICS INC | Healthcare | 0.9% | $10.4m | 1,379,965 | 0% | held |
| 21 | SLDB SOLID BIOSCIENCES INC | Healthcare | 0.8% | $9.2m | 2,481,400 | – | new |
| 22 | SVRA SAVARA INC | Healthcare | 0.8% | $9.0m | 3,257,639 | – | new |
| 23 | ABVX ABIVAX SA | 0.7% | $8.4m | 1,345,780 | 0% | held | |
| 24 | PERCEPTIVE CAP SOLUTIONS COR | 0.7% | $7.7m | 750,000 | 0% | held | |
| 25 | SRZN SURROZEN INC | 0.6% | $7.4m | 632,931 | – | new | |
| 26 | ZURA ZURA BIO LTD | Healthcare | 0.6% | $6.5m | 5,023,166 | 148% | added |
| 27 | ARTV ARTIVA BIOTHERAPEUTICS INC | 0.4% | $4.8m | 1,609,569 | 0% | held | |
| 28 | TRVI TREVI THERAPEUTICS INC | Healthcare | 0.3% | $3.9m | 615,506 | -51% | reduced |
| 29 | APLT APPLIED THERAPEUTICS INC | 0.2% | $2.7m | 5,567,709 | -44% | reduced | |
| 30 | FDMT 4D MOLECULAR THERAPEUTICS IN | 0.2% | $2.2m | 677,600 | -77% | reduced | |
| 31 | CASIF CASI PHARMACEUTICALS INC | 0.2% | $2.1m | 987,259 | 0% | held | |
| 32 | TENX TENAX THERAPEUTICS INC | 0.1% | $1.4m | 208,333 | 0% | held | |
| 33 | MERSANA THERAPEUTICS INC | 0.1% | $1.2m | 3,574,325 | -65% | reduced | |
| 34 | IPSC CENTURY THERAPEUTICS INC | Healthcare | 0.1% | $1.2m | 2,498,069 | -37% | reduced |
| 35 | TNYA TENAYA THERAPEUTICS INC | 0.1% | $886.8k | 1,555,556 | 0% | held | |
| 36 | GLYCEUR GLYCOMIMETICS INC | 0.1% | $630.0k | 3,000,000 | 0% | held | |
| 37 | TIL INSTIL BIO INC | 0.0% | $576.0k | 33,177 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.